SCHEMBL2029371

SCHEMBL2029371

c1ccc2c(-c3nccnn3)n[nH]c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 5/20 0.54
IDO1 P14902 3/20 0.53
KDM4E B2RXH2 3/20 0.53
GAA P10253 2/20 0.53
ALDH1A1 P00352 2/20 0.53
TTK P33981 2/20 0.53
ALPL P05186 1/20 0.53
HPGD P15428 1/20 0.53
MAPK10 P53779 1/20 0.53
MAP2K4 P45985 2/20 0.46
ITK Q08881 3/20 0.44
FGFR1 P11362 1/20 0.44
FLT1 P17948 1/20 0.44
AURKA O14965 1/20 0.44
MAPK1 P28482 1/20 0.43
MAPKAPK3 Q16644 1/20 0.43
MAPK6 Q16659 1/20 0.43
PDPK1 O15530 1/20 0.43
CYP3A4 P08684 1/20 0.43
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1287897 0.84 LRRK2 (0.68) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL27717171 0.77 MKNK1 (0.58) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL1672674 0.75 IDO1 (0.78) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL1328336 0.70 LRRK2 (1.00) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL30316298 0.70 LRRK2 (1.00) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL855531 0.70 ALDH1A1 (1.00) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL30768403 0.70 ALDH1A1 (1.00) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL17313371 0.70 HSD17B10 (0.51) KDM4EGAAALDH1A1MAPK1CYP3A4
SCHEMBL28376527 0.70 LRRK2 (0.68) LRRK2IDO1KDM4EGAAALDH1A1
SCHEMBL30130217 0.70 LRRK2 (0.68) LRRK2IDO1KDM4EGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2011116786-A 3-(INDAZOL-5-YL)-(1, 2, 4) TRIAZINE DERIVATIVE AND RELATED COMPOUND AS PROTEIN KINASE INHIBITOR FOR TREATING CANCER SCHERING CORP 2011-06-16 JP disclosed